- Health Spotlight's Spinal Muscular Atrophy Insights
- Posts
- Weekly Spotlight - 31.10.24
Weekly Spotlight - 31.10.24
Advancements in research, awareness initiatives, and new tools for understanding and managing SMA.
Community |
Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters! |
In the News |
Developing Murine Models for Rare Neuromuscular Disease Research |
Sarah Holbrook's dissertation explores creating and testing murine models for rare neuromuscular diseases like SMARD1. Using CRISPR, various models were developed, revealing insights into IGHMBP2-related conditions. Gene therapy showed promise, potentially broadening treatment options. This scientific journey highlights the importance of animal models in understanding and curing rare diseases. |
Exploring Genetic Modifiers in Spinal Muscular Atrophy Research |
In the quest for Spinal Muscular Atrophy (SMA) disease modifiers, researchers explore genetic and epigenetic factors that influence disease severity. While SMN2 is a well-known modifier, others like Plastin 3 and NAIP are emerging. Understanding these could lead to new therapies and better patient outcomes. |
Chloe and Becca, living with spinal muscular atrophy, share their experiences for Breast Cancer Awareness Month. Chloe adapted her method; Becca sought help from her mum. Stay informed and proactive with support services and updates. |
Limb-Girdle Weakness and Hypertrophy: Consider Spinal Muscular Atrophy |
Spinal muscular atrophy (SMA) is primarily characterized by muscle weakness, but it can also present with muscle hypertrophy. A case study involving a 24-year-old male with SMA type 4 revealed limb-girdle weakness alongside unexpected muscle bulking, which resembled muscular dystrophy. This highlights the importance of not dismissing SMA when observing unusual muscle development. |
Health Spotlight’s Spinal Muscular Atrophy is a Contentive publication in the Healthcare division